CRISPR Knockout Lentivirus Library
abm‘s CRISPR Knockout sgRNA lentiviruses and lentiviral vectors are highly effective. We offer a collection of sgRNA vectors and viruses targeting any human, mouse, or rat gene for use with spCas9. In addition to sgRNA-only vectors, we also offer an All-In-One lentiviral option, which expresses sgRNA and spCas9 nuclease from the same vector.
Key Features
- Collection of sgRNAs for knockout of your gene of interest with spCas9. Human, mouse, and rat gene targets are available.
- Lentiviral delivery for integration of genetic material into host cells, leading to long term gene expression.
- Available expressing sgRNA alone, or as an All-In-One construct which expresses both sgRNA and spCas9.
- A set of three sgRNA vectors/viruses is available for added assurance of efficient gene knockout.
For multiplex gRNA expression from lentiviral vector, use our Custom Multiplex gRNA Service.
For knockout of up to 100 target genes, take advantage of our pooled Custom Targeted Lentiviral sgRNA Library Service.
Popular Products
- 2nd Gen. Packaging Mix & Lentifectin Combo Pack
- Lentivirus Titration Kit
- ViralPlus Transduction Enhancer
- CRISPR Control Vectors and Viruses
- Titer Upgrade Services
Additional Resources on CRISPR Technology
Search Library
Primary Cells Collection
We offer a wide variety of primary cell lines
across more than 20 different cell systems.
Can’t find the cell line you’re looking for? Contact info@itsbio.co.kr.
abm web site 제품 검색 입니다.
Product Information
Performance/Data
Click to see our CRISPR Knockout Case Study, including experimental design and supporting data.
How to use abm‘s sgRNA lentivectors and lentiviruses in your CRISPR knockout experiment.
Top Publications
| 01 |
Regulation of NKT cell-mediated immune responses to tumours and liver inflammation by mitochondrial PGAM5-Drp1 signalling.
|
| 02 |
Isorhapontigenin (ISO) inhibits invasive bladder cancer (BC) formation in vivo and human BC invasion in vitro by targeting STAT1/FOXO1 Axis. Jiang, G. et al. Cancer Prev Res. Published Online First April 14, 2016. doi: 10.1158/1940-6207.CAPR-15-0338
|
| 03 | Clinical significance of SNORA42 as an oncogene and a prognostic biomarker in colorectal cancer. Okugawa, Y et al. Gut (2015) doi:10.1136/gutjnl-2015-309359 |
Browse Products
Unit: 1.0 μg per target, 5 x 200 μl, 300 μl per target, 1.0 ml, 1 x 106 cells/1.0 ml
Unit: 1.0 μg per target, 5 x 200 μl, 300 μl per target, 1.0 ml, 1 x 106 cells/1.0 ml
Unit: 1.0 μg per target, 5 x 200 μl, 300 μl per target, 1.0 ml, 1 x 106 cells/1.0 ml
Unit: 1.0 μg per target, 5 x 200 μl, 300 μl per target, 1.0 ml, 1 x 106 cells/1.0 ml
Unit: 1.0 μg per target, 5 x 200 μl, 300 μl per target, 1.0 ml, 1 x 106 cells/1.0 ml
Unit: 1.0 μg per target, 5 x 200 μl, 300 μl per target, 1.0 ml, 1 x 106 cells/1.0 ml
Unit: 1.0 μg per target, 5 x 200 μl, 300 μl per target, 1.0 ml, 1 x 106 cells/1.0 ml
Unit: 1.0 μg per target, 5 x 200 μl, 300 μl per target, 1.0 ml, 1 x 106 cells/1.0 ml
Unit: 1.0 μg per target, 5 x 200 μl, 300 μl per target, 1.0 ml, 1 x 106 cells/1.0 ml
Unit: 1.0 μg per target, 5 x 200 μl, 300 μl per target, 1.0 ml, 1 x 106 cells/1.0 ml
